STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells

被引:28
作者
Rahimi, AAR
Gee, K
Mishra, S
Lim, W
Kumar, A
机构
[1] Childrens Hosp Eastern Ontario, Div Virol & Mol Immunol, Res Inst, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada
关键词
D O I
10.4049/jimmunol.174.12.7823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-10, an anti-inflammatory cytokine, has been shown to exhibit stimulatory functions including CD14 up-regulation on human monocytic cells. CD14-mediated signaling following LPS stimulation of monocytic cells results in the synthesis of proinflammatory cytokines. Our results show that LPS-induced CD14 expression on monocytic cells may be mediated by endogenously produced IL-10. To investigate the molecular mechanism by which IL-10 enhances CD14 expression, both human monocytes and the promyelocytic HL-60 cells were used as model systems. IL-10 induced the phosphorylation of PI3K and p42/44 ERK MAPK. By using specific inhibitors for PI3K (LY294002) and ERK MAPKs (PD98059), we demonstrate that LY294002 either alone or in conjunction with PD98059 inhibited IL-10-induced phosphorylation of STAT-1 and consequently CD14 expression. However, IL-10-induced STAT-3 phosphorylation remained unaffected under these conditions. Finally, STAT-1 interfering RNA inhibited IL-10-induced CD14 expression. Taken together, these results suggest that IL-10-induced CD14 up-regulation in human monocytic cells may be mediated by STAT-1 activation through the activation of PI3K either alone or in concert with the ERK MAPK.
引用
收藏
页码:7823 / 7832
页数:10
相关论文
共 58 条
[1]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[2]   Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation [J].
Berlato, C ;
Cassatella, MA ;
Kinjyo, I ;
Gatto, L ;
Yoshimura, A ;
Bazzoni, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6404-6411
[3]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[4]   HUMAN INTERLEUKIN-10 INDUCES NAIVE SURFACE-IMMUNOGLOBULIN D+ (SIGD(+)) B-CELLS TO SECRETE IGG1 AND IGG3 [J].
BRIERE, F ;
SERVETDELPRAT, C ;
BRIDON, J ;
SAINTREMY, JM ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :757-762
[5]   Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons [J].
Burfoot, MS ;
Rogers, NC ;
Watling, D ;
Smith, JM ;
Pons, S ;
Paonessaw, G ;
Pellegrini, S ;
White, MF ;
Kerr, IM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) :24183-24190
[6]   Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine [J].
Crawley, JB ;
Williams, LM ;
Mander, T ;
Brennan, FM ;
Foxwell, BMJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :16357-16362
[7]   Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10 [J].
Creery, D ;
Angel, JB ;
Aucoin, S ;
Weiss, W ;
Cameron, WD ;
Diaz-Mitoma, F ;
Kumar, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (06) :1212-1221
[8]  
Daftarian PM, 1996, J IMMUNOL, V157, P12
[9]   Phosphoinositide 3-kinase: Diverse roles in immune cell activation [J].
Deane, JA ;
Fruman, DA .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :563-598
[10]  
DELPRETE G, 1993, J IMMUNOL, V150, P353